论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
依那西普联合糖皮质激素和丙种球蛋白治疗儿童中毒性表皮坏死松解症一例报告
Authors Fu Y, Xiao Y, Gao T, Zhang J, Wang T
Received 8 October 2023
Accepted for publication 29 December 2023
Published 23 January 2024 Volume 2024:17 Pages 167—171
DOI https://doi.org/10.2147/CCID.S440476
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Anne-Claire Fougerousse
Abstract: Toxic epidermal necrolysis (TEN) is a type of drug eruption in dermatology emergencies that is rare in clinical practice but has a high mortality rate. The main causes are drug and viral infections. Unfortunately, no expert consensus on treating this disease exists, and a standard therapy is absent. Up to now, glucocorticoids combined with gamma globulin are commonly used in clinical practice, but their efficacy is highly controversial. This study reports on a 7-year-old girl with TEN who did not respond to traditional therapy, such as methylprednisolone combined with gamma globulin, but was finally cured with an additional low-dose etanercept. The results showed that etanercept therapy in paediatric TEN is safe, reliable and worth recommending.
Keywords: child toxic epidermal necrolysis, etanercept, glucocorticoids, gamma globulin